Literature DB >> 15297508

MICs of selected antibiotics for Bacillus anthracis, Bacillus cereus, Bacillus thuringiensis, and Bacillus mycoides from a range of clinical and environmental sources as determined by the Etest.

Peter C B Turnbull1, Nicky M Sirianni, Carlos I LeBron, Marian N Samaan, Felicia N Sutton, Anatalio E Reyes, Leonard F Peruski.   

Abstract

This paper presents Etest determinations of MICs of selected antimicrobial agents for 76 isolates of Bacillus anthracis chosen for their diverse histories and 67, 12, and 4 cultures, respectively, of its close relatives B. cereus, B. thuringiensis, and B. mycoides derived from a range of clinical and environmental sources. NCCLS breakpoints are now available for B. anthracis and ciprofloxacin, penicillin, and tetracycline; based on these breakpoints, the B. anthracis isolates were all fully susceptible to ciprofloxacin and tetracycline, and all except four cultures, three of which had a known history of penicillin resistance and were thought to originate from the same original parent, were susceptible to penicillin. Based on NCCLS interpretive standards for gram-positive and/or aerobic bacteria, all cultures were susceptible to amoxicillin-clavulanic acid and gentamicin and 99% (one with intermediate sensitivity) of cultures were susceptible to vancomycin. No group trends were apparent among the different categories of B. cereus (isolates from food poisoning incidents and nongastrointestinal infections and food and environmental specimens not associated with illness). Differences between B. anthracis and the other species were as expected for amoxicillin and penicillin, with all B. anthracis cultures, apart from the four referred to above, being susceptible versus high proportions of resistant isolates for the other three species. Four of the B. cereus and one of the B. thuringiensis cultures were resistant to tetracycline and a further six B. cereus and one B. thuringiensis cultures fell into the intermediate category. There was a slightly higher resistance to azithromycin among the B. anthracis strains than for the other species. The proportion of B. anthracis strains fully susceptible to erythromycin was also substantially lower than for the other species, although just a single B. cereus strain was fully resistant. The Etest compared favorably with agar dilution in a subsidiary test set up to test the readings, and it compared with other published studies utilizing a variety of test methods.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15297508      PMCID: PMC497625          DOI: 10.1128/JCM.42.8.3626-3634.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  32 in total

1.  In vitro development of resistance to ofloxacin and doxycycline in Bacillus anthracis Sterne.

Authors:  C H Choe; S S Bouhaouala; I Brook; T B Elliot; G B Knudson
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

2.  Antibiotic susceptibilities of 96 isolates of Bacillus anthracis isolated in France between 1994 and 2000.

Authors:  Jean-Didier Cavallo; Francoise Ramisse; Monique Girardet; Josée Vaissaire; Michelle Mock; Eric Hernandez
Journal:  Antimicrob Agents Chemother       Date:  2002-07       Impact factor: 5.191

3.  Biochemical characterization of beta-lactamases Bla1 and Bla2 from Bacillus anthracis.

Authors:  Isabel C Materon; Anne Marie Queenan; Theresa M Koehler; Karen Bush; Timothy Palzkill
Journal:  Antimicrob Agents Chemother       Date:  2003-06       Impact factor: 5.191

4.  SUCCESSFUL TREATMENT OF RHESUS MONKEYS FOR SEPTICEMIA ANTHRAX.

Authors:  R E LINCOLN; F KLEIN; J S WALKER; B W HAINES; W I JONES; B G MAHLANDT; R H FRIEDMAN
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1964

5.  Antimicrobial susceptibility of Bacillus anthracis.

Authors:  M Doğanay; N Aydin
Journal:  Scand J Infect Dis       Date:  1991

6.  Antimicrobial susceptibility testing of Bacillus anthracis: comparison of results obtained by using the National Committee for Clinical Laboratory Standards broth microdilution reference and Etest agar gradient diffusion methods.

Authors:  M Jasmine Mohammed; Chung K Marston; Tanja Popovic; Robbin S Weyant; Fred C Tenover
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

7.  Beta-lactamase genes of the penicillin-susceptible Bacillus anthracis Sterne strain.

Authors:  Yahua Chen; Janice Succi; Fred C Tenover; Theresa M Koehler
Journal:  J Bacteriol       Date:  2003-02       Impact factor: 3.490

8.  Antimicrobial susceptibilities of 40 isolates of Bacillus anthracis isolated in Turkey.

Authors:  Duygu Esel; Mehmet Doganay; Bulent Sumerkan
Journal:  Int J Antimicrob Agents       Date:  2003-07       Impact factor: 5.283

9.  The genome sequence of Bacillus anthracis Ames and comparison to closely related bacteria.

Authors:  Timothy D Read; Scott N Peterson; Nicolas Tourasse; Les W Baillie; Ian T Paulsen; Karen E Nelson; Hervé Tettelin; Derrick E Fouts; Jonathan A Eisen; Steven R Gill; Erik K Holtzapple; Ole Andreas Okstad; Erlendur Helgason; Jennifer Rilstone; Martin Wu; James F Kolonay; Maureen J Beanan; Robert J Dodson; Lauren M Brinkac; Michelle Gwinn; Robert T DeBoy; Ramana Madpu; Sean C Daugherty; A Scott Durkin; Daniel H Haft; William C Nelson; Jeremy D Peterson; Mihai Pop; Hoda M Khouri; Diana Radune; Jonathan L Benton; Yasmin Mahamoud; Lingxia Jiang; Ioana R Hance; Janice F Weidman; Kristi J Berry; Roger D Plaut; Alex M Wolf; Kisha L Watkins; William C Nierman; Alyson Hazen; Robin Cline; Caroline Redmond; Joanne E Thwaite; Owen White; Steven L Salzberg; Brendan Thomason; Arthur M Friedlander; Theresa M Koehler; Philip C Hanna; Anne-Brit Kolstø; Claire M Fraser
Journal:  Nature       Date:  2003-05-01       Impact factor: 49.962

Review 10.  Bacillus cereus and related species.

Authors:  F A Drobniewski
Journal:  Clin Microbiol Rev       Date:  1993-10       Impact factor: 26.132

View more
  45 in total

1.  Pre- and postexposure protection against virulent anthrax infection in mice by humanized monoclonal antibodies to Bacillus anthracis capsule.

Authors:  Zhaochun Chen; Rachel Schneerson; Julie Lovchik; C Rick Lyons; Huaying Zhao; Zhongdong Dai; Joanna Kubler-Kielb; Stephen H Leppla; Robert H Purcell
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-27       Impact factor: 11.205

2.  Multiplex PCR-ligation detection reaction assay for simultaneous detection of drug resistance and toxin genes from Staphylococcus aureus, Enterococcus faecalis, and Enterococcus faecium.

Authors:  K Granger; M S Rundell; M R Pingle; R Shatsky; D H Larone; L M Golightly; F Barany; E D Spitzer
Journal:  J Clin Microbiol       Date:  2009-10-28       Impact factor: 5.948

3.  Metal ions weaken the hydrophobicity and antibiotic resistance of Bacillus subtilis NCIB 3610 biofilms.

Authors:  Carolina Falcón García; Martin Kretschmer; Carlos N Lozano-Andrade; Markus Schönleitner; Anna Dragoŝ; Ákos T Kovács; Oliver Lieleg
Journal:  NPJ Biofilms Microbiomes       Date:  2020-01-03       Impact factor: 7.290

4.  Host cell cytotoxicity and cytoskeleton disruption by CerADPr, an ADP-ribosyltransferase of Bacillus cereus G9241.

Authors:  Nathan C Simon; James M Vergis; Avesta V Ebrahimi; Christy L Ventura; Alison D O'Brien; Joseph T Barbieri
Journal:  Biochemistry       Date:  2013-03-20       Impact factor: 3.162

5.  Bacillus cereus Certhrax ADP-ribosylates vinculin to disrupt focal adhesion complexes and cell adhesion.

Authors:  Nathan C Simon; Joseph T Barbieri
Journal:  J Biol Chem       Date:  2014-02-26       Impact factor: 5.157

Review 6.  The Bacillus cereus Group: Bacillus Species with Pathogenic Potential.

Authors:  Monika Ehling-Schulz; Didier Lereclus; Theresa M Koehler
Journal:  Microbiol Spectr       Date:  2019-05

7.  Pediatric anthrax clinical management.

Authors:  John S Bradley; Georgina Peacock; Steven E Krug; William A Bower; Amanda C Cohn; Dana Meaney-Delman; Andrew T Pavia
Journal:  Pediatrics       Date:  2014-05       Impact factor: 7.124

8.  An extracytoplasmic function sigma factor controls beta-lactamase gene expression in Bacillus anthracis and other Bacillus cereus group species.

Authors:  Cana L Ross; Kerrie S Thomason; Theresa M Koehler
Journal:  J Bacteriol       Date:  2009-08-28       Impact factor: 3.490

9.  The small acid soluble proteins (SASP alpha and SASP beta) of Bacillus weihenstephanensis and Bacillus mycoides group 2 are the most distinct among the Bacillus cereus group.

Authors:  Courtney Callahan; Karen Fox; Alvin Fox
Journal:  Mol Cell Probes       Date:  2009-07-17       Impact factor: 2.365

10.  Isolation and chimerization of a highly neutralizing antibody conferring passive protection against lethal Bacillus anthracis infection.

Authors:  Ronit Rosenfeld; Hadar Marcus; Einat Ben-Arie; Bat-El Lachmi; Adva Mechaly; Shaul Reuveny; Orit Gat; Ohad Mazor; Arie Ordentlich
Journal:  PLoS One       Date:  2009-07-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.